Mehmet Ozturk

Citata da

	Tutte	Dal 2016
Citazioni	10307	1704
Indice H	46	21
i10-index	91	39

460

230

115

345

198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202135 27 56 112 310 358 376 403 294 311 280 316 350 315 347 284 336 308 369 308 304 307 306 387 400 423 448 395 340 352 350 333 322 5

Coautori

Jack Wandsprofessor of medicine,Brown UniversityEmail verificata su brown.edu
Rengul Cetin AtalayUniversity of Chicago and Middle East Technical UniversityEmail verificata su metu.edu.tr
Dominique BELLETProfesseur d'immunologie, Université Paris DescartesEmail verificata su parisdescartes.fr
Serif SenturkResearch Group Leader at Izmir Biomedicine and Genome CenterEmail verificata su ibg.edu.tr
Ozge gursoy YuzugulluDana Farber Cancer Institute, Harvard Medical SchoolEmail verificata su dfci.harvard.edu
Frederique PonchelThe University of Leeds (LIRMM, TRIMID)Email verificata su leeds.ac.uk
YAKICIERProfessor of Molecular Biology and Genetics ACIBADEM UniversityEmail verificata su acibadem.com.tr
HALUK YUZUGULLUAstrazeneca PharmaceuticalsEmail verificata su astrazeneca.com
Hiroshi TakahashiTexas Instruments JapanEmail verificata su ti.com
Cigdem Ozen, Ph.D.Specialist at Izmir International Biomedicine and Genome Institute, iBG-izmir, Dokuz EylülEmail verificata su deu.edu.tr
Nuri OzturkProfessor @ Gebze Technical UniversityEmail verificata su gtu.edu.tr
Ayça Arslan ErgülUNAM, Bilkent UniversityEmail verificata su bilkent.edu.tr
Tamer YagciEmail verificata su gyte.edu.tr
Gokhan YildizKaradeniz Technical University School of Medicine Department of Medical BiologyEmail verificata su ktu.edu.tr
Hilal Ozdag PhDAnkara University Biotechnology InstituteEmail verificata su ankara.edu.tr
Isik G. YulugAssociate Professor of Molecular Biology and Genetics, Bilkent UniversityEmail verificata su fen.bilkent.edu.tr
Bert VogelsteinJohns HopkinsEmail verificata su jhmi.edu
Tolga CagatayUT Southwestern Medical Center at DallasEmail verificata su utsouthwestern.edu
Berna S. SayanUniversity of ManchesterEmail verificata su manchester.ac.uk
Thierry soussiProfessor of Molecular BiologyEmail verificata su ki.se

Mehmet Ozturk

Izmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, Turkey

Email verificata su deu.edu.tr - Home page

Molecular Biology Genetics Cell Biology Cancer


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Selective G to T mutations of p 53 gene in hepatocellular carcinoma from southern Africa B Bressac, M Kew, J Wands, M Ozturk Nature 350 (6317), 429-431, 1991	1643	1991
p53 functions as a cell cycle control protein in osteosarcomas. L Diller, J Kassel, CE Nelson, MA Gryka, G Litwak, M Gebhardt, B Bressac, ... Molecular and cellular biology 10 (11), 5772-5781, 1990	957	1990
p53 mutation in hepatocellular carcinoma after aflatoxin exposure B Bressac, A Puisieux, M Kew, M Volkmann, S Bozcall, JB Mura, ... The Lancet 338 (8779), 1356-1359, 1991	567	1991
P53 HOTSPOT MUTATION IN HEPATOCELLULAR-CARCINOMA IS LINKED TO AFLATOXIN EXPOSURE M Ozturk, B BRESSAC, A Puisieux, M Kew, M Volkmann, S Bozcali, ... HEPATOLOGY 14 (4), A94-A94, 1991	567*	1991
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma B Bressac, KM Galvin, TJ Liang, KJ Isselbacher, JR Wands, M Ozturk Proceedings of the National Academy of Sciences 87 (5), 1973-1977, 1990	517	1990
Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway JP Rouault, N Falette, F Guéhenneux, C Guillot, R Rimokh, Q Wang, ... Nature genetics 14 (4), 482-486, 1996	453	1996
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens A Puisieux, S Lim, J Groopman, M Ozturk Cancer research 51 (22), 6185-6189, 1991	360	1991
Human MLH1 deficiency predisposes to hematological maligancy and neurofibromatosis type 1 MD Ricciardone, T Özçelik, B Cevher, H Özdağ, M Tuncer, A Gürgey, ... Cancer research 59 (2), 290, 1999	271	1999
Systems medicine and integrated care to combat chronic noncommunicable diseases J Bousquet, JM Anto, PJ Sterk, IM Adcock, KF Chung, J Roca, A Agusti, ... Genome Medicine 3 (7), 1-12, 2011	265	2011
Genetic aspects of hepatocellular carcinogenesis. M Ozturk Seminars in liver disease 19 (3), 235-242, 1998	246	1998
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik, A Toylu, N Tasdemir, ... Molecular cancer 8 (1), 90, 2009	223	2009
Smad2 and Smad4 gene mutations in hepatocellular carcinoma MC Yakicier, MB Irmak, A Romano, M Kew, M Ozturk Oncogene 18 (34), 4879, 1999	211	1999
Genetic heterogeneity of hepatocellular carcinoma H Unsal, C Yakicier, C Marcais, M Kew, M Volkmann, H Zentgraf, ... Proceedings of the National Academy of Sciences 91 (2), 822-826, 1994	204	1994
PATIKA: an integrated visual environment for collaborative construction and analysis of cellular pathways E Demir, O Babur, U Dogrusoz, A Gursoy, G Nisanci, R Cetin-Atalay, ... Bioinformatics 18 (7), 996-1003, 2002	198	2002
Transforming growth factor‐beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth S Senturk, M Mumcuoglu, O Gursoy‐Yuzugullu, B Cingoz, KC Akcali, ... Hepatology 52 (3), 966-974, 2010	185	2010
Evaluation of cytotoxicity and oxidative DNA damaging effects of di (2-ethylhexyl)-phthalate (DEHP) and mono (2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and … P Erkekoglu, W Rachidi, OG Yuzugullu, B Giray, A Favier, M Ozturk, ... Toxicology and applied pharmacology 248 (1), 52-62, 2010	179	2010
Redundant expression of canonical Wnt ligands in human breast cancer cell lines K Benhaj, KC Akcali, M Ozturk Oncology reports 15 (3), 701-707, 2006	175	2006
Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines A Puisieux, K Galvin, F Troalen, B Bressac, C Marcais, E Galun, ... The FASEB journal 7 (14), 1407-1413, 1993	156	1993
Physiological studies of human chorionic gonadotropin (hCG), αhCG, and βhCG as measured by specific monoclonal immunoradiometric assays M OZTURK, D BELLET, LUC MANIL, G HENNEN, R FRYDMAN, ... Endocrinology 120 (2), 549-558, 1987	156	1987
P53 mutation as a source of aberrant β-catenin accumulation in cancer cells T Cagatay, M Ozturk Oncogene 21 (52), 7971, 2002	115	2002

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Carica PDF

Segui questo autore

Citata da

Coautori